Creo Medical Group (CREO)

Sector:

Health Care

Index:

FTSE AIM All-Share

 36.25p
   
  • Change Today:
      0.000p
  • 52 Week High: 48.10
  • 52 Week Low: 23.25
  • Currency: UK Pounds
  • Shares Issued: 361.48m
  • Volume: 299,147
  • Market Cap: £131.04m

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Christopher Paul Hancock 4,802,352 £1,740,853
Richard John Rees 2,805,902 £1,017,140
Craig Jonathan Gulliford 1,630,466 £591,044
John Bradshaw 1,371,082 £497,017
David Gerard Woods 440,255 £159,592
Charles Spicer 308,530 £111,842
Ivonne Cantu 125,000 £45,312

Major Shareholders

Notifier** Holding Value*
Canaccord Genuity Group Inc 39,303,064 £14,247,361
Development Bank of Wales plc 14,376,727 £5,211,564
Finance Wales 12,776,727 £4,631,564
Baillie Gifford & Co 12,537,441 £4,544,822
Creo Medical Group EBT 10,000,000 £3,625,000
M&G Investments 9,428,500 £3,417,831
The Capital Group Companies, Inc. 8,816,807 £3,196,092
AXA Framlington Investment Managers 7,992,961 £2,897,448
Hargreave Hale Limited 6,753,632 £2,448,192
Tellworth Investments 5,772,778 £2,092,632
Hoya Corporation 4,799,880 £1,739,956
Jonathan Craton 3,400,294 £1,232,607
Cotterford Co Limited 3,335,398 £1,209,082
Mark Farmer 3,121,607 £1,131,582
RBC Trustees (CI) Ltd 2,974,727 £1,078,338
Angel Co Fund 2,967,120 £1,075,581

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

CREO Market Data

Currency UK Pounds
Share Price 36.25p
Change Today 0.000p
% Change 0.00 %
52 Week High 48.10
52 Week Low 23.25
Volume 299,147
Shares Issued 361.48m
Market Cap £131.04m

CREO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
23.43% below the market average23.43% below the market average23.43% below the market average23.43% below the market average23.43% below the market average
35.48% below the sector average35.48% below the sector average35.48% below the sector average35.48% below the sector average35.48% below the sector average
Price Trend
13.89% above the market average13.89% above the market average13.89% above the market average13.89% above the market average13.89% above the market average
35.14% above the sector average35.14% above the sector average35.14% above the sector average35.14% above the sector average35.14% above the sector average
Income Not Available
Growth
42.70% above the market average42.70% above the market average42.70% above the market average42.70% above the market average42.70% above the market average
66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

CREO Dividends

No dividends found

Trades for 26-Apr-2024

Time Volume / Share Price
16:21 3,491 @ 36.50p
16:04 35,000 @ 36.40p
16:00 5,627 @ 36.18p
15:57 1,369 @ 36.50p
15:57 50 @ 36.50p

CREO Key Personnel

CEO Craig Jonathan Gulliford
CFO Richard John Rees

Top of Page